Walleye Capital LLC Repligen Corp Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.79 - $167.35 $1.47 Million - $2.06 Million
-12,300 Reduced 34.55%
23,300 $3.47 Million
Q2 2024

Aug 14, 2024
SELL
$120.0 - $182.95 $828,000 - $1.26 Million
-6,900 Reduced 16.24%
35,600 $4.49 Million
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $5.38 Million - $6.57 Million
31,500 Added 286.36%
42,500 $7.82 Million
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $1.14 Million - $1.85 Million
-10,000 Reduced 47.62%
11,000 $1.98 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $1.83 Million - $2.33 Million
13,200 Added 169.23%
21,000 $3.34 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $1.08 Million - $1.41 Million
7,800 New
7,800 $1.1 Million
Q1 2020

May 15, 2020
SELL
$84.96 - $109.14 $237,887 - $305,592
-2,800 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$73.84 - $93.08 $1.31 Million - $1.66 Million
-17,800 Reduced 86.41%
2,800 $259,000
Q3 2019

Nov 14, 2019
SELL
$76.65 - $95.51 $2.34 Million - $2.91 Million
-30,500 Reduced 59.69%
20,600 $1.58 Million
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $2.44 Million - $3.87 Million
45,000 Added 737.7%
51,100 $4.39 Million
Q1 2019

May 15, 2019
BUY
$49.45 - $62.8 $301,645 - $383,080
6,100 New
6,100 $360,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email